These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 17889116

  • 1. mTOR inhibitors: do they help preserve renal function?
    Moro J, Almenar L, Martínez-Dolz L, Agüero J, Rueda J, Arnau MA, Izquierdo M, Cano O, Sánchez-Lázaro I, Salvador A.
    Transplant Proc; 2007 Sep; 39(7):2135-7. PubMed ID: 17889116
    [Abstract] [Full Text] [Related]

  • 2. mTOR inhibitors and their secondary effects in cardiac transplant recipients: a descriptive study.
    Moro J, Almenar L, Martínez-Dolz L, Izquierdo M, Rueda J, Arnau MA, Agüero J, Sánchez-Lázaro I, Ortiz V, Salvador A.
    Transplant Proc; 2007 Sep; 39(7):2365-7. PubMed ID: 17889191
    [Abstract] [Full Text] [Related]

  • 3. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
    Castroagudín JF, Molina E, Romero R, Otero E, Tomé S, Varo E.
    Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140
    [Abstract] [Full Text] [Related]

  • 4. Early renal benefit of rapamycin combined with reduced calcineurin inhibitor dose in pediatric heart transplantation patients.
    Balfour IC, Srun SW, Wood EG, Belsha CW, Marshall DL, Ferdman BR.
    J Heart Lung Transplant; 2006 May; 25(5):518-22. PubMed ID: 16678029
    [Abstract] [Full Text] [Related]

  • 5. Recovery of renal function in heart transplantation patients after conversion from a calcineurin inhibitor-based therapy to sirolimus.
    Ayub-Ferreira SM, Avila MS, Feitosa FS, Souza GE, Mangini S, Marcondes-Braga FG, Issa VS, Bacal F, Chizzola PR, Cruz FD, Bocchi EA.
    Transplant Proc; 2010 Mar; 42(2):542-4. PubMed ID: 20304188
    [Abstract] [Full Text] [Related]

  • 6. First experience with rapamycin-based immunosuppression to improve kidney function after heart transplantation.
    Trösch F, Rothenburger M, Schneider M, Welp H, Etz C, Wilhelm MJ, Scheld HH, Schmid C.
    Thorac Cardiovasc Surg; 2004 Jun; 52(3):163-8. PubMed ID: 15192777
    [Abstract] [Full Text] [Related]

  • 7. Sirolimus experience in heart transplantation.
    Aranda-Dios A, Lage E, Sobrino JM, Mogollón MV, Guisado A, Cabezón S, Hinojosa R, Hernández A, Ordóñez A.
    Transplant Proc; 2006 Oct; 38(8):2547-9. PubMed ID: 17097997
    [Abstract] [Full Text] [Related]

  • 8. Calcineurin inhibitor-free immunosuppression using everolimus (Certican) in maintenance heart transplant recipients: 6 months' follow-up.
    Rothenburger M, Teerling E, Bruch C, Lehmkuhl H, Suwelack B, Bara C, Wichter T, Hinder F, Schmid C, Stypmann J.
    J Heart Lung Transplant; 2007 Mar; 26(3):250-7. PubMed ID: 17346627
    [Abstract] [Full Text] [Related]

  • 9. Sirolimus as an alternative to anticalcineurin therapy in heart transplantation: experience of a single center.
    Fernandez-Valls M, Gonzalez-Vilchez F, de Prada JA, Ruano J, Ruisanchez C, Martin-Duran R.
    Transplant Proc; 2005 Nov; 37(9):4021-3. PubMed ID: 16386615
    [Abstract] [Full Text] [Related]

  • 10. Improvement of renal dysfunction by conversion from calcineurin inhibitors to sirolimus after heart transplantation.
    Hunt J, Lerman M, Magee MJ, Dewey TM, Herbert M, Mack MJ.
    J Heart Lung Transplant; 2005 Nov; 24(11):1863-7. PubMed ID: 16297793
    [Abstract] [Full Text] [Related]

  • 11. Sirolimus-based immunosuppression after cardiac transplantation: predictors of recovery from calcineurin inhibitor-induced renal dysfunction.
    Gustafsson F, Ross HJ, Delgado MS, Bernabeo G, Delgado DH.
    J Heart Lung Transplant; 2007 Oct; 26(10):998-1003. PubMed ID: 17919619
    [Abstract] [Full Text] [Related]

  • 12. Preservation of renal function after heart transplantation: initial single-center experience with sirolimus.
    De Meester JM, Van Vlem B, Walravens M, Vanderheyden M, Verstreken S, Goethals M, Kerre N, Wellens F.
    Transplant Proc; 2005 May; 37(4):1835-8. PubMed ID: 15919481
    [Abstract] [Full Text] [Related]

  • 13. Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity.
    Kushwaha SS, Khalpey Z, Frantz RP, Rodeheffer RJ, Clavell AL, Daly RC, McGregor CG, Edwards BS.
    J Heart Lung Transplant; 2005 Dec; 24(12):2129-36. PubMed ID: 16364861
    [Abstract] [Full Text] [Related]

  • 14. Clinical implications of proteinuria in renal transplant recipients switching to rapamycin for chronic allograft dysfunction.
    Gutiérrez MJ, González E, Andrés A, Morales JM.
    Transplant Proc; 2009 Dec; 41(6):2348-50. PubMed ID: 19715916
    [Abstract] [Full Text] [Related]

  • 15. Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients.
    Raichlin E, Khalpey Z, Kremers W, Frantz RP, Rodeheffer RJ, Clavell AL, Edwards BS, Kushwaha SS.
    Transplantation; 2007 Aug 27; 84(4):467-74. PubMed ID: 17713429
    [Abstract] [Full Text] [Related]

  • 16. Impact on renal function of the use of sirolimus in cardiac transplantation.
    Ubilla M, Mastrobuoni S, Cordero A, Castaño S, Herreros J, Rábago G.
    Transplant Proc; 2007 Sep 27; 39(7):2401-2. PubMed ID: 17889202
    [Abstract] [Full Text] [Related]

  • 17. Predictors of long-term renal function after conversion to proliferation signal inhibitors in long-term heart transplant recipients.
    González-Vilchez F, de Prada JA, Castrillo C, Canteli A, Llano MF, Martín-Durán R.
    J Heart Lung Transplant; 2011 May 27; 30(5):552-7. PubMed ID: 21212001
    [Abstract] [Full Text] [Related]

  • 18. Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients.
    Nair S, Eason J, Loss G.
    Liver Transpl; 2003 Feb 27; 9(2):126-9. PubMed ID: 12548505
    [Abstract] [Full Text] [Related]

  • 19. Complete switch to everolimus in long-term kidney transplants: evolution of the renal function.
    Fernández A, Marcén R, Galeano C, Caldés S, Amezquita Y, Villafruela J, Pascual J, Burgos J, Rodríguez-Mendiola N, Ortuño J.
    Transplant Proc; 2009 Feb 27; 41(6):2345-7. PubMed ID: 19715915
    [Abstract] [Full Text] [Related]

  • 20. Improvement in renal function and rejection control in pediatric liver transplant recipients with the introduction of sirolimus.
    Casas-Melley AT, Falkenstein KP, Flynn LM, Ziegler VL, Dunn SP.
    Pediatr Transplant; 2004 Aug 27; 8(4):362-6. PubMed ID: 15265163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.